341 related articles for article (PubMed ID: 26459756)
1. A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.
McNamara AL; Schuemann J; Paganetti H
Phys Med Biol; 2015 Nov; 60(21):8399-416. PubMed ID: 26459756
[TBL] [Abstract][Full Text] [Related]
2. Investigating the impact of alpha/beta and LET
Mara E; Clausen M; Khachonkham S; Deycmar S; Pessy C; Dörr W; Kuess P; Georg D; Gruber S
Med Phys; 2020 Aug; 47(8):3691-3702. PubMed ID: 32347564
[TBL] [Abstract][Full Text] [Related]
3. The experimental dose ranges influence the LET
Rørvik E; Thörnqvist S; Ytre-Hauge KS
Phys Med Biol; 2019 Sep; 64(19):195001. PubMed ID: 31357190
[TBL] [Abstract][Full Text] [Related]
4. A phenomenological biological dose model for proton therapy based on linear energy transfer spectra.
Rørvik E; Thörnqvist S; Stokkevåg CH; Dahle TJ; Fjaera LF; Ytre-Hauge KS
Med Phys; 2017 Jun; 44(6):2586-2594. PubMed ID: 28295379
[TBL] [Abstract][Full Text] [Related]
5. A model for the relative biological effectiveness of protons: the tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes.
Wedenberg M; Lind BK; Hårdemark B
Acta Oncol; 2013 Apr; 52(3):580-8. PubMed ID: 22909391
[TBL] [Abstract][Full Text] [Related]
6. Exploration and application of phenomenological RBE models for proton therapy.
Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
[TBL] [Abstract][Full Text] [Related]
7. A phenomenological relative biological effectiveness approach for proton therapy based on an improved description of the mixed radiation field.
Mairani A; Dokic I; Magro G; Tessonnier T; Bauer J; Böhlen TT; Ciocca M; Ferrari A; Sala PR; Jäkel O; Debus J; Haberer T; Abdollahi A; Parodi K
Phys Med Biol; 2017 Feb; 62(4):1378-1395. PubMed ID: 28114106
[TBL] [Abstract][Full Text] [Related]
8. Modeling RBE with other quantities than LET significantly improves prediction of in vitro cell survival for proton therapy.
Kalholm F; Grzanka L; Toma-Dasu I; Bassler N
Med Phys; 2023 Jan; 50(1):651-659. PubMed ID: 36321465
[TBL] [Abstract][Full Text] [Related]
9. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
[TBL] [Abstract][Full Text] [Related]
10. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
11. Systematics of relative biological effectiveness measurements for proton radiation along the spread out Bragg peak: experimental validation of the local effect model.
Grün R; Friedrich T; Krämer M; Scholz M
Phys Med Biol; 2017 Feb; 62(3):890-908. PubMed ID: 28072575
[TBL] [Abstract][Full Text] [Related]
12. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.
Paganetti H
Phys Med Biol; 2014 Nov; 59(22):R419-72. PubMed ID: 25361443
[TBL] [Abstract][Full Text] [Related]
13. RBE variation in prostate carcinoma cells in active scanning proton beams: In-vitro measurements in comparison with phenomenological models.
Khachonkham S; Mara E; Gruber S; Preuer R; Kuess P; Dörr W; Georg D; Clausen M
Phys Med; 2020 Sep; 77():187-193. PubMed ID: 32871460
[TBL] [Abstract][Full Text] [Related]
14. Is the dose-averaged LET a reliable predictor for the relative biological effectiveness?
Grün R; Friedrich T; Traneus E; Scholz M
Med Phys; 2019 Feb; 46(2):1064-1074. PubMed ID: 30565705
[TBL] [Abstract][Full Text] [Related]
15. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
16. An empirical model of proton RBE based on the linear correlation between x-ray and proton radiosensitivity.
Flint DB; Ruff CE; Bright SJ; Yepes P; Wang Q; Manandhar M; Ben Kacem M; Turner BX; Martinus DKJ; Shaitelman SF; Sawakuchi GO
Med Phys; 2022 Sep; 49(9):6221-6236. PubMed ID: 35831779
[TBL] [Abstract][Full Text] [Related]
17. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
Henry T; Ödén J
Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
[TBL] [Abstract][Full Text] [Related]
18. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
Paganetti H
Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
[TBL] [Abstract][Full Text] [Related]
19. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
Giantsoudi D; Adams J; MacDonald SM; Paganetti H
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
[TBL] [Abstract][Full Text] [Related]
20. Clinical radiobiology of proton therapy: modeling of RBE.
Jones B
Acta Oncol; 2017 Nov; 56(11):1374-1378. PubMed ID: 28820311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
